AI-Enabled Structural Vaccinology Using Gemini to Accelerate Antigen Discovery
11:30 am - Thursday 30th July 2026
- Sharing a case-study on the development of an AI/ML tool that pairs structural similarity and functional features to identify novel vaccine targets
- Understanding how structure-based epitope mapping is revolutionizing the design of antibodies by identifying key binding sites on complex antigens, leading to higher affinity and specificity in vaccine development
- Exploring how high-resolution structural data can be applied to design vaccines with enhanced stability, reduced immunogenicity, and improved pharmacokinetic properties
